Coblopasvir

Coblopasvir is a pan-genotypic NS5A inhibitor used to study Hepatitis C virus infection. It is applied in both in vitro and in vivo research to investigate viral replication mechanisms and evaluate potential antiviral therapies for chronic HCV.

Product Specifications

CAS Number

1312608-46-0

Product Name Alternative

Chronic hepatitis C virus infection, Coblopasvir, Inhibitor, Hepatitis C virus, HCV, HCV Protease, inhibit, NS5A, KW 136, KW136, KW-136, pangenotypic regimen

Field of Research

Infectious Disease & Virology, Protein Biochemistry

Purity

99.33% (May vary between batches)

Smiles

C ([C@@H] (NC (OC) =O) C (C) C) (=O) N1[C@H] (C=2NC (C3=C4C (=C (C=C3) C5=CC=C (C=C5) C=6NC (=NC6) [C@H]7N (C ([C@@H] (NC (OC) =O) [C@@H] (C) C) =O) CCC7) OCO4) =CN2) CCC1